FBXW7 is involved in Aurora B degradation

Cell Cycle

Volumn 11, Issue 21, 2012, Pages 4059-4068

  Teng, Chieh Lin ^a,b,c,d   Hsieh, Yun Chi ^a,b   Phan, Liem ^a   Shin, Jihyun ^a   Gully, Chris ^a,e   Velazquez Torres, Guermarie ^a   Skerl, Stephen ^a   Yeung, Sai Ching J ^a   Hsu, Shih Lan ^b   Lee, Mong Hong ^a,e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Aurora B; FBXW7; p53; Ubiquitination

Indexed keywords

AURORA B KINASE; F BOX AND WD REPEAT DOMAIN CONTAINING 7; F BOX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CORRELATION ANALYSIS; DOWN REGULATION; GENE OVEREXPRESSION; MITOSIS; MULTINUCLEAR CELL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; UBIQUITINATION;

EID: 84869434906     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22381     Document Type: Article

References (45)

1. Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003; 4:842-54; PMID:14625535; http://dx.doi.org/10.1038/nrm1245.
2. Ruchaud S, Carmena M, Earnshaw WC. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007; 8:798-812; PMID:17848966; http://dx.doi.org/10.1038/nrm2257.
3. Lindqvist A, Rodríguez-Bravo V, Medema RH. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 2009; 185:193-202; PMID:19364923; http://dx.doi.org/10.1083/jcb.200812045.
4. Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007; 5:1-10; PMID:17259342; http://dx.doi.org/10. 1158/1541-7786.MCR-06-0208.
5. Ducat D, Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res 2004; 301:60-7; PMID:15501446; http://dx.doi.org/10. 1016/j.yexcr.2004.08.016.
6. Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003; 22:451-64; PMID:12884918; http://dx.doi.org/10.1023/A:1023789416385.
7. Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10:825-41; PMID:21102634; http://dx.doi.org/10.1038/nrc2964.
8. Sampath SC, Ohi R, Leismann O, Salic A, Pozniakovski A, Funabiki H. The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell 2004; 118:187-202; PMID:15260989; http://dx.doi.org/10.1016/j.cell.2004.06.026.
9. Slattery SD, Moore RV, Brinkley BR, Hall RM. Aurora-C and Aurora-B share phosphorylation and regulation of CENP-A and Borealin during mitosis. Cell Cycle 2008; 7:787-95; PMID:18239465; http://dx.doi.org/10.4161/cc.7.6.5563.
10. Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 2006; 6:776-88; PMID:16990855; http://dx.doi.org/10.1038/nrc1994.
11. Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7:3307-13; PMID:18948752; http://dx.doi.org/10.4161/cc.7.21.6931.
12. Malyukova A, Dohda T, von der Lehr N, Akhoondi S, Corcoran M, Heyman M, et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res 2007; 67:5611-6; PMID:17575125; http://dx.doi.org/10.1158/0008-5472. CAN-06-4381.
13. Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007; 67:9006-12; PMID:17909001; http://dx.doi.org/10.1158/0008-5472.CAN-07- 1320.
14. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290.
15. Minella AC, Clurman BE. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 2005; 4:1356-9; PMID:16131838; http://dx.doi.org/10.4161/cc.4.10. 2058.
16. Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004; 432:775-9; PMID:15592418; http://dx.doi.org/10.1038/nature03155.
17. Spruck CH, Strohmaier H, Sangfelt O, Müller HM, Hubalek M, Müller-Holzner E, et al. hCDC4 gene mutations in endometrial cancer. Cancer Res 2002; 62:4535-9; PMID:12183400.
18. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428:77-81; PMID:14999283; http://dx.doi.org/10.1038/nature02313.
19. Knuutila S, Aalto Y, Autio K, Björkqvist AM, El-Rifai W, Hemmer S, et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155:683-94; PMID:10487825; http://dx.doi.org/10.1016/S0002-9440(10)65166-8.
20. Grim JE, Gustafson MP, Hirata RK, Hagar AC, Swanger J, Welcker M, et al. Isoform- and cell cycledependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 2008; 181:913-20; PMID:18559665; http://dx.doi.org/10.1083/ jcb.200802076.
21. Gully CP, Velazquez-Torres G, Shin JH, Fuentes-Mattei E, Wang E, Carlock C, et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci USA 2012; 109:E1513-22; PMID:22611192; http://dx.doi.org/10.1073/ pnas.1110287109.
22. Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, et al. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem 2004; 279:50110-9; PMID:15364936; http://dx.doi.org/10. 1074/jbc.M409226200.
23. Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G, et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204:1825-35; PMID:17646408; http://dx.doi.org/10.1084/ jem.20070872.
24. Gully CP, Zhang F, Chen J, Yeung JA, Velazquez-Torres G, Wang E, et al. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Mol Cancer 2010; 9:42; PMID:20175926; http://dx.doi.org/10.1186/1476-4598-9-42.
25. Knauer SK, Mann W, Stauber RH. Survivin's dual role: an export's view. Cell Cycle 2007; 6:518-21; PMID:17361097; http://dx.doi.org/10.4161/cc.6.5.3902.
26. Lens SM, Rodriguez JA, Vader G, Span SW, Giaccone G, Medema RH. Uncoupling the central spindleassociated function of the chromosomal passenger complex from its role at centromeres. Mol Biol Cell 2006; 17:1897-909; PMID:16436504; http://dx.doi.org/10.1091/mbc.E05-08-0727.
27. Jelluma N, Brenkman AB, van den Broek NJ, Cruijsen CW, van Osch MH, Lens SM, et al. Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment. Cell 2008; 132:233-46; PMID:18243099; http://dx.doi.org/ 10.1016/j.cell.2007.11.046.
28. Ricke RM, van Deursen JM. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell Cycle 2011; 10:3645-51; PMID:22033440; http://dx.doi.org/10.4161/cc.10.21.18156.
29. Nguyen HG, Chinnappan D, Urano T, Ravid K. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol Cell Biol 2005; 25:4977-92; PMID:15923616; http://dx.doi.org/10.1128/MCB.25.12.4977-4992.2005.
30. Stewart S, Fang G. Destruction box-dependent degradation of aurora B is mediated by the anaphasepromoting complex/cyclosome and Cdh1. Cancer Res 2005; 65:8730-5; PMID:16204042; http://dx.doi.org/10.1158/0008-5472.CAN-05-1500.
31. Sumara I, Quadroni M, Frei C, Olma MH, Sumara G, Ricci R, et al. A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells. Dev Cell 2007; 12:887-900; PMID:17543862; http://dx.doi.org/10.1016/j.devcel.2007.03.019.
32. Yeung SC, Gully C, Lee MH. Aurora-B kinase inhibitors for cancer chemotherapy. Mini Rev Med Chem 2008; 8:1514-25; PMID:19075809; http://dx.doi.org/10.2174/138955708786786480.
33. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4:927-36; PMID:15573114; http://dx.doi.org/10.1038/nrc1502.
34. Sanhaji M, Friel CT, Wordeman L, Louwen F, Yuan JP. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target. Oncotarget 2011; 2:935-47; PMID:22249213.
35. Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, et al. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett 2012; 586:1409-18; PMID:22673505; http://dx.doi.org/10.1016/j.febslet.2012.03. 017.
36. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, et al. Phosphorylationdependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116-25; PMID:15103331; http://dx.doi.org/10.1038/ sj.emboj.7600217.
37. Orlicky S, Tang X, Willems A, Tyers M, Sicheri F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 2003; 112:243-56; PMID:12553912; http://dx.doi.org/10.1016/S0092- 8674(03)00034-5.
38. Jin J, Ang XL, Shirogane T, Wade Harper J. Identification of substrates for F-box proteins. Methods Enzymol 2005; 399:287-309; PMID:16338364; http://dx.doi.org/10.1016/S0076-6879(05)99020-4.
39. Wu CC, Yang TY, Yu CT, Phan L, Ivan C, Sood AK, et al. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation. Cell Cycle 2012; 11:3433-42; PMID:22894933.
40. Chiang CM. p53-Aurora A mitotic feedback loop regulates cell cycle progression and genomic stability. Cell Cycle 2012; 11: In press; PMID:22982999.
41. Wu LM, Ma CA, Jain A. When Aurora B met p53: newly revealed regulatory phosphorylation in an old protein. Cell Cycle 2011; 10:171-2; PMID:21212738; http://dx.doi.org/10.4161/cc.10.2.14349.
42. Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106-12; PMID:10767298; http://dx.doi.org/10.1074/jbc. M905616199.
43. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 2003; 23:7096-107; PMID:14517281; http://dx.doi.org/10.1128/MCB.23.20.7096-7107.2003.
44. Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, et al. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene 2007; 26:7355-62; PMID:17546054; http://dx.doi.org/10.1038/sj.onc.1210540.
45. Yang H, Zhao R, Lee MH. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol Cancer Ther 2006; 5:253-60; PMID:16505098; http://dx.doi.org/10.1158/1535-7163.MCT-05-0395.